What keep me excited is the fact that Constellation Pharmacueticals our number one peer currently has a market cap of $1.5 billion USD $2 billion Cad and just did a Share offering making $225 Million yet we are ahead of them in Cancer epigenetic clinical development.   So my question is why has Zenith not gone the public Share route.....? My thinking is that a buyout deal being a CVR type deal could be in the works  in the next 6 months that possibly includes RVX so no point in going public if a buyout is in the cards. This story has been going way too long but Zenith last PR gave really news on the development front 

That being said Zenith should have an EV of at least $2 Billion CAD IMO, last check my shares are listed of $2USD on TD,  There is a major disconnect in value  Here is hoping for a prosperous 2020 fro both Zenith and RVX